Industry Background:
A breast augmentation implant is referred to as the prosthesis which is been used to change the shape, size, and contour of an woman's breast. In an reconstructive plastic surgery, basically, breast implants can be placed so that to restore a totally natural looking breast mound for a post-mastectomy breast reconstruction patients or to correct the congenital defects and deformities of the chest wall. They are also used in cosmetically to enhance or enlarge appearance of the breast through the breast augmentation surgery. In short breast augmentation implant are the medical devices which are implanted under the breast tissue or under the chest muscle to increase the breast size which is also called as implantation or to rebuild breast tissue after mastectomy or other damage to the breast (reconstruction).This growth is primarily driven by The rise in global disposable income
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Volume Unit | N |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Medical Devices sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Allergan (Ireland), Mentor Worldwide (Johnson & Johnson) (United States), GC Aesthetics (Ireland), Establishment Labs (Costa Rica), Sientra (United States), POLYTECH Health & Aesthetics (Germany), Laboratoires Arion (France), Groupe Sebbin (France), Hans Biomed (South Korea) and Guangzhou Wanhe Plastic Materials (China), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Groupe Sebbin announced the global launch of its newest range of breast implants, Integrity. This new generation Nano-textured implants uses the latest technology by introducing the " NanoSkinTM Concept " developed by the Technological Research Department of Groupe Sebbin
Regulatory Insights:
The FDA approved Mentor's PMA for a silicone gel-filled breast implant that uses a more cohesive silicone gel, compared to their previously approved breast implant. As a condition of approval, the manufacturer was required to conduct a series of post-approval studies to further characterize the safety and effectiveness of their breast implant and to answer scientific questions that the premarket clinical trial was not designed to answer
Breast Augmentation Implant Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - The rise in global disposable income
- Growth in reimbursement rates for reconstructive procedures
|
Influencing Trends | - Availability of premium-priced products
- Expansion of the product portfolio
|
Restraints | - Risk of developing serious complications
- Lack of skilled nursing facilities in developing regions
|
Road Blocks / Challenges | - High risk of malfunctions and low reimbursement rates
|
Gaps & Opportunities | - Advanced surgical technology is creating an opportunity in the market
|
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Breast Augmentation Implant Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Breast Augmentation Implant Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols:
By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Breast Augmentation Implant players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Breast Augmentation Implant Study Sheds Light on
The Breast Augmentation Implant Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Breast Augmentation Implant industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Breast Augmentation Implant industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.